This partnership brings together Remidio’s Medios DR AI for automated DR detection and RetinaRisk’s personalised risk ...

Vantage Biosciences has dosed the first subject in the randomised Phase II trial of oral therapy VX-01 to treat ...

Diabetes affects more than 101 million people in India today. The number is estimated to reach 125 million by the year 2045.

Dr. Michael Kapusta, MD, FRSCS, Ophthalmologist, talks about advanced (proliferative) diabetic retinopathy and pars plana ...

Dr. Mohan’s Diabetes Specialities Centre (DMDSC) on Tuesday launched an AI-driven software to detect diabetic retinopathy at its Thanjavur Centre ...

With vision loss due to diabetes emerging as one of the most serious yet overlooked complications in India, Firstpost brings ...

Diabetic retinopathy (DR), a serious eye condition caused by damage to the blood vessels in the retina—the light-sensitive tissue at the back of the eye—is a ma ...

India's first AI-driven software by Dr. Mohan's Diabetes Specialities Centre detects early retinal damage for improved patient outcomes.

Below a specific threshold, FCP exerts a protective effect, but above that threshold the protective effect becomes uncertain.

A group of 18 African ophthalmologists have successfully completed a one-year specialized training program in Diabetic ...

In diabetes care, AI has propelled the field forward through predictive modeling, decision support, and real-time glycemic ...